- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Matrizyme Pharma Corporation
Total 453 results
-
Mitsubishi Tanabe Pharma CorporationCompletedPeripheral Vascular DiseaseUnited States, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationTerminatedPeripheral Vascular DiseaseUnited States, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationRecruiting
-
Orion Corporation, Orion PharmaActive, not recruitingProstate Cancer MetastaticFrance, United Kingdom, Finland, United States
-
Mitsubishi Tanabe Pharma CorporationCompletedJapanese Patients With ALSJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedHealthy Adult SubjectsJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedHealthy Adult SubjectsJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAnemia; Hemodialysis Dependent Chronic Kidney DiseaseJapan
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedOsteoarthritis, Knee / Osteoarthritis, HipJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedHealthy | Severe Hepatic ImpairmentCzechia, Hungary, Slovakia
-
Orion Corporation, Orion PharmaTerminatedAmyotrophic Lateral SclerosisCanada, United States, Australia, Germany, Belgium, Finland, Spain, Austria, Italy, France, Ireland, Netherlands, Sweden, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedPainful Diabetic Peripheral NeuropathyJapan
-
Orion Corporation, Orion PharmaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusChina
-
Orion Corporation, Orion PharmaCompletedHealthy VolunteersFinland
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Orion Corporation, Orion PharmaCompletedSolid TumoursFrance, Finland, Spain, Italy, Denmark, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Asahi Kasei Pharma CorporationCompleted
-
Orion Corporation, Orion PharmaCompletedCerumen Impaction of Both EarsLithuania
-
Asahi Kasei Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)Japan
-
Orion Corporation, Orion PharmaCompletedParkinson's DiseaseFinland, Germany, Hungary, Latvia
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedAmyotrophic Lateral Sclerosis (ALS)
-
Orion Corporation, Orion PharmaCompletedAmyotrophic Lateral SclerosisIreland, Netherlands, United Kingdom, Germany
-
Orion Corporation, Orion PharmaCompleted
-
Orion Corporation, Orion PharmaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedPlaque Psoriasis | Psoriatic Arthritis | Psoriatic Erythroderma | Pustular Psoriasis (Excluding a Localized)Japan
-
Orion Corporation, Orion PharmaCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Asahi Kasei Pharma CorporationCompletedDisseminated Intravascular CoagulationJapan
-
Asahi Kasei Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompletedBehcet Syndrome | Behcet's Disease | Neuro-Behcet's DiseaseJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedCrohn's DiseaseFrance, Israel, Italy, Netherlands, Poland, Slovakia, Ukraine, Czech Republic, Germany, Hungary, Japan
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompletedPerennial Allergic RhinitisJapan
-
Mitsubishi Tanabe Pharma CorporationTerminated
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Asahi Kasei Pharma CorporationCompleted
-
Mitsubishi Tanabe Pharma CorporationTerminatedChronic Kidney Disease | Hyperphosphatemia | Dialysis | PaediatricUnited Kingdom
-
Orion Corporation, Orion PharmaCompletedParkinson's DiseaseGermany, Sweden, United Kingdom
-
Mitsubishi Tanabe Pharma CorporationCompleted